research use only
Cat.No.S4885
| Related Targets | Integrase Antibiotics Anti-infection Fungal Antiviral COVID-19 Parasite Reverse Transcriptase HIV HCV Protease |
|---|---|
| Other Bacterial Inhibitors | Berberine BTZ043 Racemate Teicoplanin Pefloxacin Mesylate Ornidazole Proanthocyanidins Solithromycin Skatole Berberine Sulfate Furagin |
|
In vitro |
DMSO
: 56 mg/mL
(196.93 mM)
|
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 284.36 | Formula | C7H16N4O4S2 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 19388-87-5 | -- | Storage of Stock Solutions |
|
|
| Synonyms | Taurolin, Tauroline, Tauroflex | Smiles | C1CS(=O)(=O)NCN1CN2CCS(=O)(=O)NC2 | ||
| In vitro |
Taurolidine inhibits the growth of a rat metastatic colorectal tumor cell line in vitro. This compound possesses antineoplastic activity. The antiproliferative IC50 of this chemical is in the 10-50 μM range, approximately 100-fold lower that that required for its antibiotic effects. Exposure to this agent induces apoptosis in SKOV-3 and PA-1 human tumor cells but apparently not in NIH-3T3 fibroblasts. It causes significant in vitro growth inhibition and cytotoxicity of human MM cells, which appears to be due, at least in part, to apoptosis.
|
|---|---|
| In vivo |
In BD IX rats that underwent laparotomy, intraperitoneal instillation of DHD/K12/TRb tumor cells, local/intraperitoneal administration of taurolidine results in a marked decrease in tumor burden compared with control animals. The i.p. administration of this compound effectively inhibits the development and growth of ovarian tumors when therapy is initiated on the day of tumor cell injection. i.p. taurolidine inhibits adherence of colon tumor cells injected into the peritoneal cavity of rats.
|
References |
|
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT02279121 | Completed | Catheter-Related Infections |
Centre Hospitalier Régional Metz-Thionville|centre régional de pharmacovigilance de Nancy|Theradial |
November 2014 | Not Applicable |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.